Inhibition of endothelial activation: A new way to treat cerebral malaria?

PLoS Medicine

Volumn 2, Issue 9, 2005, Pages 0885-0890

  Wassmer, Samuel C ^a,c   Cianciolo, George J ^b   Combes, Valéry ^a   Grau, Georges E ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c QUEEN ELIZABETH CENTRAL HOSPITAL   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; INTERCELLULAR ADHESION MOLECULE 1; PURINE DERIVATIVE; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; 2 AMINO 6 CHLORO 9 ((5 DIHYDROXYBORYL)PENTYL)PURINE; 2-AMINO-6-CHLORO-9-((5-DIHYDROXYBORYL)PENTYL)PURINE; ANTIMALARIAL AGENT; BORON DERIVATIVE; CD40 ANTIGEN; PURINE NUCLEOSIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRAIN MALARIA; CELL ADHESION; DATA ANALYSIS; DRUG STRUCTURE; ENDOTHELIUM CELL; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; PARASITISM; PLASMODIUM FALCIPARUM; TRANSCRIPTION INITIATION; UPREGULATION; ANIMAL; CELL LINE; DRUG EFFECT; ISOLATION AND PURIFICATION; METABOLISM; PARASITOLOGY; TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD40; ANTIMALARIALS; BORON COMPOUNDS; CELL ADHESION; CELL LINE; ENDOTHELIAL CELLS; ERYTHROCYTES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; PLASMODIUM FALCIPARUM; PURINE NUCLEOSIDES; PURINES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 25644448837     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020245     Document Type: Article

References (25)

1. Barnwell JW (1989) Cytoadherence and sequestration in falciparum malaria. Exp Parasitol 69: 407-412.
2. Atkinson CT, Aikawa M (1990) Ultrastructure of malaria-infected erythrocytes. Blood Cells 16: 351-368.
3. Grau GE, Mackenzie CD, Carr RA, Redard M, Pizzolato G, et al. (2003) Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. J Infect Dis 187: 461-466.
4. Turner GD, Ly VC, Nguyen TH, Tran TH, Nguyen HP, et al. (1998) Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol 152: 1477-1487.
5. Combes V, Taylor TE, Juhan-Vague I, Mege JL, Mwenechanya J, et al. (2004) Circulating endothelial microparticles in Malawian children with severe falciparum malaria complicated with coma. JAMA 291: 2542-2544.
6. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, et al. (1989) Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320: 1586-1591.
7. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, et al. (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201-1204.
8. Molyneux ME, Engelmann H, Taylor TE, Wirima JJ, Aderka D, et al. (1993) Circulating plasma receptors for tumour necrosis factor in Malawian children with severe falciparum malaria. Cytokine 5: 604-609.
9. Engwerda CR, Mynott TL, Sawhney S, De Souza JB, Bickle QD, et al. (2002) Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med 195: 1371-1377.
10. Hunt NH, Grau GE (2003) Cytokines: Accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 24: 491-499.
11. Bevilacqua MP, Gimbrone MA Jr. (1987) Inducible endothelial functions in inflammation and coagulation. Semin Thromb Hemost 13: 425-433.
12. Dorovini-Zis K, Prameya R, Bowman PD (1991) Culture and characterization of microvascular endothelial cells derived from human brain. Lab Invest 64: 425-436.
13. Trager W, Jensen JB (1976) Human malaria parasites in continuous culture. Science 193: 673-675.
14. Heidrich HG, Mrema JE, Vander Jagt DL, Reyes P, Rieckmann KH (1982) Isolation of intracellular parasites (Plasmodium falciparum) from culture using free-flow electrophoresis: Separation of the free parasites according to stages. J Parasitol 68: 443-450.
15. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, et al. (1999) In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 104: 93-102.
16. Pouvelle B, Fusai T, Lepolard C, Gysin J (1998) Biological and biochemical characteristics of cytoadhesion of Plasmodium falciparum-infected erythrocytes to chondroitin-4-sulfate. Infect Immun 66: 4950-4956.
17. Newbold C, Warn P, Black G, Berendt A, Craig A, et al. (1997) Receptorspecific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg 57: 389-398.
18. van Hensbroek MB, Palmer A, Onyiorah E, Schneider G, Jaffar S, et al. (1996) The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 174: 1091-1097.
19. Kremsner PG, Grundmann H, Neifer S, Sliwa K, Sahlmuller G, et al. (1991) Pentoxifylline prevents murine cerebral malaria. J Infect Dis 164: 605-608.
20. Lee SW, Tsou AP, Chan H, Thomas J, Petrie K, et al. (1988) Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A 85: 1204-1208.
21. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, et al. (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 177: 1675-1680.
22. Grau GE, Maennel DN (1997) TNF inhibition and sepsis: Sounding a cautionary note. Nat Med 3: 1193-1195.
23. Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344: 907-916.
24. Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358: 903-911.
25. Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, et al. (2003) Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial. Arthritis Rheum 48: 35-45.